Motokura T, Bloom T, Kim HG, Jüppner H, Ruderman JV, Kronenberg HM, Arnold A. 1991. A novel cyclin encoded by a BCL1-linked candidate oncogene. Nature, 350:512-5.

Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature, 369:669-71.

Hosokawa Y, Arnold A. 1998. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer, 22:66-71.

Palanisamy N, Imanishi Y, Rao PH, Tahara H, Chaganti RS, Arnold A. 1998. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. J Clin Endocrinol Metab, 83:1766-1770.

Oyama T, Kashiwabara K, Yoshimoto K, Arnold A , Koerner F. 1998. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res, 58:2876-2880.

Carling T, Imanishi Y, Gaz RD, Arnold A. 1999. Analysis of the RAD54 gene on chromosome 1p as a potential tumor suppressor gene in parathyroid adenomas. Int J Cancer, 83:80-82.

Chung DC, Brown SB, Graeme-Cook F, Seto M, Warshaw AL, Jensen RT, Arnold A. 2000. Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J Clin Endocrinol Metab, 85:4373-8.

Hosokawa Y, Papanikolaou A, Cardiff RD, Yoshimoto K, Bernstein M, Wang TC, Schmidt EV, Arnold A. 2001. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53. Transgenic Res 2001;10: 471-478.

Imanishi Y, Hosokawa Y, Yoshimoto K, Schipani E, Mallya S, Papanikolaou A, Kifor O, Tokura T, Sablosky M, Ledgard F, Gronowicz G, Wang TC, Schmidt EV, Hall C, Brown EM, Bronson R, Arnold A. 2001. Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest, 107:1093-1102.